By Frank Prenesti
Date: Tuesday 11 Oct 2022
(Sharecast News) - Shares in healthcare company PureTech fell on Tuesday as the company said it and US-based Nektar Therapeutics had ended merger talks only four days after they announced a potential tie up.
By Michele Maatouk
Date: Friday 07 Oct 2022
(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.
By Michele Maatouk
Date: Friday 07 Oct 2022
(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.
No recent information was found.
Currency | US Dollars |
Share Price | $ 23.36 |
Change Today | $ 0.63 |
% Change | 2.77 % |
52 Week High | $23.97 |
52 Week Low | $7.36 |
Volume | 1,275,612 |
Shares Issued | 180.09m |
Market Cap | $4,206.93m |
RiskGrade | 333 |
Strong Buy | 3 |
Buy | 3 |
Neutral | 1 |
Sell | 1 |
Strong Sell | 0 |
Total | 8 |
Time | Volume / Share Price |
16:00 | 35,996 @ $23.36 |
15:59 | 100 @ $23.39 |
15:59 | 800 @ $23.39 |
15:59 | 100 @ $23.38 |
15:59 | 100 @ $23.37 |
You are here: research